| 中文别名 |
胆固醇脂转移蛋白阻滞剂;安塞曲匹;(4S,5R)-5-(3,5-双(三氟甲基)苯基)-3-((4-氟-2-甲氧基-4-(三氟甲基)-[1,1-联苯]-2-基)甲基)-4-甲基噁唑啉-2-酮;Anacetrapib (MK-0859) 抑制剂;anacetrapib标准品;安塞曲匹Anacetrapib;安塞曲匹API;安赛曲匹;(4S,5R)-5-(3,5-双(三氟甲基)苯基)-3-((4'-氟-5'-异丙基-2'-甲氧基-4-(三氟甲基)-[1,1' -联苯]-2-基)甲基)-4-甲基噁唑烷-2-酮 |
| 英文别名 |
Anacetrapib;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one;Anacetrapib (MK-0859);MK0859;MK-0859;UNII-P7T269PR6S;P7T269PR6S;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one;Anacetrapib [USAN:INN];Anacetrapib (JAN/USAN);cc-7;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone (ACI);(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one;MK 0859;(4S,5R)-5-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-((4'-FLUORO-2'-METHOXY-5'-(PROPAN-2-YL)-4-(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-2-YL)METHYL)-4-METHYL-1,3-OXAZOLIDIN-2-ONE;NS00072888;(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one.;ANACETRAPIB [MI];15?-Hydroxy Testosterone;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-5'isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one;(15a,17ss)-15,17-Dihydroxyandrost-4-en-3-one; NSC 60794;;MFCD16294903;DTXSID90236452;(4s,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one;DB06630;Anacetrapib(MK0859)?;CCG-270307;s2748;EX-A420;NCGC00346671-01;BCP9000299;SMR004701293;J-501484;Q4750639;Anacetrapib [USAN];BCPP000402;(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl)methyl)-4-methyloxazolidin-2-one;ANACETRAPIB [MART.];GTPL8400;AS-19552;BDBM50348228;(4S,5r)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl)methyl)-4-methyl-1 ,3-oxazolidin-2-one;SCHEMBL531448;CHEMBL1800807;ANACETRAPIB [WHO-DD];HY-12090;ANACETRAPIB [INN];BCP02374;15a-Hydroxy Testosterone;15alpha-Hydroxy Testosterone (1mg/ml in Acetonitrile);(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-5'isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl}4-methyl-1,3-oxazolidin-2-one;875446-37-0;(4S,5R)-5-(3,5-Bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one;ANACETRAPIB [JAN];AC-25517;AKOS025290725;CS-0636;(4S,5R)-5-(3,5-bis(Trifluoromethyl)phenyl)-3-((4'-fluoro-2'-methoxy-5'-(propan-2- yl)-4-(trifluoromethyl)(1,1'-biphenyl)-2-yl)methyl)-4-methyl-1,3-oxazolidin-2-one;MLS006010190;2... |